Michael J. Fox appears in the April Issue of AARP The Magazine

Michael J. Fox appears in AARP Magazine

Photo courtesy of AARP The Magazine

All eyes are on Michael J. Fox as he graces the current issue of AARP The Magazine.  Michael talks about family, his return to TV and keeping a positive outlook on life when living with Parkinson’s:

“There’s an idea I came across a few years ago that I love. My happiness grows in direct proportion [to] my acceptance and in inverse proportion to my expectations.”

MJFF’s CEO Todd Sherer, PhD, also spoke with AARP The Magazine on biotech company Ceregene and their work with the neurturin gene therapy CERE-120 as a potential disease-modifying treatment for PD. MJFF has been a lead funder for this promising therapeutic since 2005, which is currently in stage 2 clinical development:

“At the moment, all eyes are on a promising surgical therapy involving a specialized brain protein called neurturin, which may slow or stop Parkinson’s symptoms rather than temporarily mask them. In testing, neurturin has been found to help rejuvenate neurons damaged by Parkinson’s, and restore function.”

Michael also encourages those inspired by the Foundation’s work to get involved with clinical trials by registering as a volunteer on Fox Trial Finder:

“The more people get involved in trials, the quicker our work carries on, and accelerates research down the pathway to the bedside.”